Elevance Health, Inc. (ELV) stock
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$429.69−0.21 (-0.05%)
Close on Nov 13, 2026Market cap $92.84BP/E 18.3Yield –
Elevance Health ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Elevance Health's ebitda for the twelve months ending Sep 30, 2026 was $6.92B, down 24.0% year over year. For fiscal 2025 it was $8.75B, down 5.5% from the year before. The highest annual figure on record is $10.24B in fiscal 2023.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.75B | -5.5% |
| FY2024 | Dec 31, 2024 | $9.26B | -9.7% |
| FY2023 | Dec 31, 2023 | $10.24B | +2.9% |
| FY2022 | Dec 31, 2022 | $9.96B | +12.4% |
| FY2021 | Dec 31, 2021 | $8.86B | +17.9% |
| FY2020 | Dec 31, 2020 | $7.51B | +5.4% |
| FY2019 | Dec 31, 2019 | $7.13B | +8.8% |
| FY2018 | Dec 31, 2018 | $6.56B | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.63B | -3.0% |
| Q2 FY2026 | Jun 30, 2026 | $2.13B | -24.1% |
| Q1 FY2026 | Mar 31, 2026 | $2.44B | -31.1% |
| Q4 FY2025 | Dec 31, 2025 | $715.00M | -33.2% |
| Q3 FY2025 | Sep 30, 2025 | $1.68B | +2.6% |
| Q2 FY2025 | Jun 30, 2025 | $2.81B | +1.4% |
| Q1 FY2025 | Mar 31, 2025 | $3.54B | +5.9% |
| Q4 FY2024 | Dec 31, 2024 | $1.07B | -54.8% |
| Q3 FY2024 | Sep 30, 2024 | $1.64B | -17.1% |
| Q2 FY2024 | Jun 30, 2024 | $2.77B | +5.2% |
| Q1 FY2024 | Mar 31, 2024 | $3.35B | +1.6% |
| Q4 FY2023 | Dec 31, 2023 | $2.37B | +36.8% |
| Q3 FY2023 | Sep 30, 2023 | $1.98B | -26.9% |
| Q2 FY2023 | Jun 30, 2023 | $2.63B | -4.1% |
| Q1 FY2023 | Mar 31, 2023 | $3.29B | +18.2% |
| Q4 FY2022 | Dec 31, 2022 | $1.73B | +7.0% |
| Q3 FY2022 | Sep 30, 2022 | $2.70B | +12.1% |
| Q2 FY2022 | Jun 30, 2022 | $2.74B | +14.6% |
| Q1 FY2022 | Mar 31, 2022 | $2.79B | +14.0% |
| Q4 FY2021 | Dec 31, 2021 | $1.62B | +80.8% |
| Q3 FY2021 | Sep 30, 2021 | $2.41B | +373.5% |
| Q2 FY2021 | Jun 30, 2021 | $2.39B | -34.4% |
| Q1 FY2021 | Mar 31, 2021 | $2.44B | -0.9% |
| Q4 FY2020 | Dec 31, 2020 | $895.00M | -33.4% |
| Q3 FY2020 | Sep 30, 2020 | $509.00M | -72.2% |
| Q2 FY2020 | Jun 30, 2020 | $3.65B | +110.8% |
| Q1 FY2020 | Mar 31, 2020 | $2.46B | +10.5% |
| Q4 FY2019 | Dec 31, 2019 | $1.34B | – |
| Q3 FY2019 | Sep 30, 2019 | $1.83B | – |
| Q2 FY2019 | Jun 30, 2019 | $1.73B | – |
| Q1 FY2019 | Mar 31, 2019 | $2.23B | – |
See a number that looks wrong?